In our study PTX3 values were significantly higher in patients over 60 years and in those with obesity (body mass index (BMI) ≥30), cardiovascular diseases and continuous systemic cortisone treatment (daily dose over 10 mg oral prednisolone) compared to those without these risk factors. This evidence concerns the gene PTX3 and cardiovascular disorder.